X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Trials

期刊標題檢索 TRIALS 最新評論: Please translate the following paragraph into English and Japanese, a... (2023-12-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Trials]您好,您是該頁面的第 65197 位訪客。

期刊簡介
期刊名稱Trials Trials
LetPub Score
5.4
50 ratings
Rate

Reputation
6.0

Influence
4.2

Speed
9.1

期刊簡稱TRIALS
ISSN1745-6215
h-index64
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.800.8120.733
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Medicine (miscellaneous)
Q2148 / 398
Category: Medicine
Subcategory: Pharmacology (medical)
Q2131 / 272

自引率 (2023-2024)5.00%自引率趨勢
掲載範囲
Trials is an open access, peer-reviewed, online journal that will encompass all aspects of the performance and findings of randomized controlled trials. Trials will experiment with, and then refine, innovative approaches to improving communication about trials. We are keen to move beyond publishing traditional trial results articles (although these will be included). We believe this represents an exciting opportunity to advance the science and reporting of trials. Prior to 2006, Trials was published as Current Controlled Trials in Cardiovascular Medicine (CCTCVM). All published CCTCVM articles are available via the Trials website and citations to CCTCVM article URLs will continue to be supported.
官方網站http://trialsjournal.biomedcentral.com
在線稿件提交http://www.trialsjournal.com/manuscript/
開放訪問Yes
出版商BioMed Central
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年2000
每年文章數773每年文章數趨勢
黃金OA百分比99.89%
OA Related Info
APC: Yes( GBP1890; USD2590; EUR2190; )
APC waiver:Check Notes
Other charges: No
Keywords: trial methodology、trial protocols、randomised controlled trials、medical trials
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3122/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1745-6215%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 4 Month(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Trials】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF CLINICAL INVESTIGATIONH-index: 447

    CiteScore: 24.50
    EMBO Molecular MedicineH-index: 90

    CiteScore: 17.70
    JOURNAL OF BIOMEDICAL SCIENCEH-index: 71

    CiteScore: 18.50
    CLINICAL SCIENCEH-index: 126

    CiteScore: 11.40
    Journal of Translational MedicineH-index: 87

    CiteScore: 10.00
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEH-index: 80

    CiteScore: 12.30
    JOURNAL OF MOLECULAR MEDICINE-JMMH-index: 127

    CiteScore: 9.30
    ARCHIVES OF MEDICAL RESEARCHH-index: 72

    CiteScore: 12.50
    Orphanet Journal of Rare DiseasesH-index: 87

    CiteScore: 6.30
    XENOTRANSPLANTATIONH-index: 56

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    Journal of Translational Medicine255701
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE172390
    JOURNAL OF CLINICAL INVESTIGATION168250
    JOURNAL OF BIOMEDICAL SCIENCE131244
    CLINICAL SCIENCE88156
    MEDICAL SCIENCE MONITOR84728
    Advances in Experimental Medicine and Biology81138
    EMBO Molecular Medicine79440
    EXPERIMENTAL BIOLOGY AND MEDICINE75991
    JOURNAL OF MOLECULAR MEDICINE-JMM75279
  •  

    Trials Trials
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [Trials] 的評論撰寫評論
作者: 寂灭骏俊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-02 18:51:14 評論於
Please translate the following paragraph into English and Japanese, and title them respectively as ":" and ":"
(0) 讚! | 寂灭骏俊

作者: Dean Hamlet


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-27 12:26:42 評論於
It seems that they are no longer accepting pre-trial protocols
(0) 讚! | Dean Hamlet

作者: 是你的志选呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-19 10:15:09 評論於
Will you still be accepting protocols in 2023?
(0) 讚! | 是你的志选呀

作者: 降龙金涛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-06 10:42:22 評論於
Still no
(0) 讚! | 降龙金涛

作者: 咏春艳苹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-01 18:23:06 評論於
Excuse me, do you still accept protocol in 2022? I remember seeing that you stopped accepting it before
(0) 讚! | 咏春艳苹

作者: 两仪艳苹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-25 22:11:53 評論於
Review speed: 12.0 | Submission hit rate: 50.0 
Experience sharing: After submitting eight months ago, it finally underwent a major revision. The reviewers are all open and their comments are very professional. There were a total of 33 issues, which were revised one by one. The reviewers were also very nice, with many comments being direct suggestions for modifications
(0) 讚! | 两仪艳苹

作者: 友翠郎


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-14 14:07:01 評論於
I finally received the minor revisions after 9 months of submission. There was one reviewer who did not respond throughout. I sent three reminder emails, but still no reply. The editor asked me to recommend another reviewer, but I was too busy to deal with it. After more than a month, it was finally accepted. It was really slow
(0) 讚! | 友翠郎

作者: 降龙金涛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-06 20:22:25 評論於
How much time did you spend from reviewers assigned to reviewers completed?
(0) 讚! | 降龙金涛

作者: 士娇酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-29 08:23:17 評論於
Research focus: protocol
Sharing of experience: Submitted on 11 Jun 2022, Reviews Completed on 13 Jul 2022, and then just kept waiting... Is it delayed?
(0) 讚! | 士娇酱吖

作者: 江南玲然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 13:26:55 評論於
How long does it take to go from reviewers assigned to under review?
(0) 讚! | 江南玲然

作者: 雨巷少年俊材


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-19 08:22:37 評論於
Can a promotion title be given with the protocol? Our unit only recognizes publications, is protocol considered a publication?
(0) 讚! | 雨巷少年俊材

作者: wfjlxy123


領域: 医学
審稿時間: 8.0 month(s)
結果: 修改後接受


撰寫評論

2022-02-23 22:47:02 評論於
Just the reviewing process was a bit slow, but the editor was very friendly and made a few minor revisions twice.
(0) 讚! | wfjlxy123

作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-10 17:52:46 評論於
Affirmative
(0) 讚! | 法慧和同

作者: 孤云梦之


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-08 12:03:48 評論於
Can I ask the experts, will Protocol still be accepted in 2022???
(0) 讚! | 孤云梦之

作者: 留云牧歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:12:27 評論於
Chinese people are causing trouble for Chinese people, while foreign experts are being accepted, domestic experts are being rejected!
(0) 讚! | 留云牧歌

作者: 咏春常青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-29 09:07:52 評論於
It has been two months since the new submission, and it has been one month since the editor was assigned. How long will it take to be reviewed?
(0) 讚! | 咏春常青

作者: 海女小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-24 22:05:47 評論於
Hello, I would like to ask why it is still in the "Editor Assigned" status after being reviewed by Xiaoxiu external audit expert
(0) 讚! | 海女小哥哥

作者: 控鹤海白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-01 23:53:38 評論於
Hello, I would like to ask if the items required in the protocol checklist need to be present in my submitted manuscript or just in the registered clinical trial protocol? And is the page and line number for each item referring to the protocol registration page or the manuscript page?
(0) 讚! | 控鹤海白

作者: 控鹤海白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-01 16:09:25 評論於
Hello, I would like to ask whether the items required by the checklist for the protocol need to be present in my submitted manuscript, or is it sufficient for them to be in my registered clinical trial protocol? Are the page and line numbers referring to the protocol registration page or the manuscript page?
(0) 讚! | 控鹤海白

作者: 东海嘉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-17 16:53:53 評論於
Requested a revision, likely under review starting from January to February
(0) 讚! | 东海嘉茂

作者: 文雯公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-30 10:27:39 評論於
Have you received it? How long did it take in total?
(0) 讚! | 文雯公子

作者: 是你的茵茵呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-29 14:24:31 評論於
Usually very fast
(0) 讚! | 是你的茵茵呀

作者: 是你的茵茵呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-28 11:02:50 評論於
Submitted on 20th December 2020, the new submission status lasted until 9th April 2021. It was then returned by the editor for formatting changes, resubmitted in mid-April, given major revisions on 10th August, minor revisions on 16th September, and formally accepted on 20th October. Exactly 10 months in total ????
(0) 讚! | 是你的茵茵呀

作者: 咏春常青


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-20 17:30:24 評論於
How long will it take to assign reviewers?
(0) 讚! | 咏春常青

作者: 东海嘉茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-09 18:48:28 評論於
How long does it take for reviewers assigned to under review?
(0) 讚! | 东海嘉茂

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [Trials] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*